Cargando…
The neurotoxicity of amyloid β-protein oligomers is reversible in a primary neuron model
Alzheimer’s disease (AD) is characterized by the accumulation of extracellular amyloid β-protein (Aβ) and intracellular hyperphosphorylated tau proteins. Recent evidence suggests that soluble Aβ oligomers elicit neurotoxicity and synaptotoxicity, including tau abnormalities, and play an initiating r...
Autores principales: | Tanokashira, Daisuke, Mamada, Naomi, Yamamoto, Fumiko, Taniguchi, Kaori, Tamaoka, Akira, Lakshmana, Madepalli K., Araki, Wataru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282621/ https://www.ncbi.nlm.nih.gov/pubmed/28137266 http://dx.doi.org/10.1186/s13041-016-0284-5 |
Ejemplares similares
-
Amyloid β-protein oligomers upregulate the β-secretase, BACE1, through a post-translational mechanism involving its altered subcellular distribution in neurons
por: Mamada, Naomi, et al.
Publicado: (2015) -
LRP1 Downregulates the Alzheimer’s β-Secretase BACE1 by Modulating Its Intraneuronal Trafficking1,2,3
por: Tanokashira, Daisuke, et al.
Publicado: (2015) -
Reversibility of Aβ oligomer neurotoxicity
por: Araki, Wataru
Publicado: (2017) -
Protection against Amyloid-β Oligomer Neurotoxicity by Small Molecules with Antioxidative Properties: Potential for the Prevention of Alzheimer’s Disease Dementia
por: Araki, Wataru, et al.
Publicado: (2022) -
Chronic Cladribine Administration Increases Amyloid Beta Peptide Generation and Plaque Burden in Mice
por: Hayes, Crystal D., et al.
Publicado: (2012)